# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
127, Journal, 0, 12, "Diabetologia", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasJournal> \"Diabetologia\"."
106431, PublicationYear, 15, 19, "2006", "", 
106430, PublicationYear, 53, 57, "2006", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasPublicationYear> \"2006\"."
130, InsulinGlargine, 66, 82, "Insulin glargine", "", 
268, Title, 66, 153, "Insulin glargine or NPH combined with metformin in type 2 diabetes : the LANMET study .", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasTitle> \"Insulin glargine or NPH combined with metformin in type 2 diabetes : the LANMET study .\"."
131, IsophaneInsulin_NPH, 86, 89, "NPH", "", 
132, Metformin, 104, 113, "metformin", "", 
133, Type2Diabetes, 117, 132, "type 2 diabetes", "", 
119895, Author, 154, 172, "Yki - J ä rvinen H", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Yki - J ä rvinen H\"."
2, Author, 181, 204, "Kauppinen - M ä kelin R", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Kauppinen - M ä kelin R\"."
3, Author, 207, 219, "Tiikkainen M", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Tiikkainen M\"."
4, Author, 222, 236, "V ä h ä talo M", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"V ä h ä talo M\"."
5, Author, 239, 248, "Virtamo H", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Virtamo H\"."
6, Author, 251, 261, "Nikkil ä K", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Nikkil ä K\"."
7, Author, 264, 273, "Tulokas T", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Tulokas T\"."
8, Author, 276, 283, "Hulme S", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Hulme S\"."
9, Author, 286, 293, "Hardy K", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Hardy K\"."
10, Author, 296, 305, "McNulty S", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"McNulty S\"."
11, Author, 308, 320, "H ä nninen J", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"H ä nninen J\"."
12, Author, 323, 334, "Lev ä nen H", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Lev ä nen H\"."
13, Author, 337, 350, "Lahdenper ä S", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Lahdenper ä S\"."
14, Author, 353, 363, "Lehtonen R", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Lehtonen R\"."
15, Author, 366, 373, "Ryysy L", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasAuthor> \"Ryysy L\"."
16, Finland, 501, 508, "Finland", "", "<http://ctro/data#Population_32828> <http://ctro/data#hasCountry> <http://ctro/data#Finland>."
273, ObjectiveDescription, 561, 723, "In type 2 diabetic patients we compared 9 months of combination therapy with insulin glargine and metformin with 9 months of NPH insulin combined with metformin .", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasObjectiveDescription> \"In type 2 diabetic patients we compared 9 months of combination therapy with insulin glargine and metformin with 9 months of NPH insulin combined with metformin .\"."
17, Type2Diabetes, 564, 579, "type 2 diabetic", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
18, Duration, 601, 609, "9 months", "", 
106429, InsulinGlargine, 633, 654, "with insulin glargine", "", 
119893, Metformin, 659, 668, "metformin", "", 
119894, Duration, 674, 682, "9 months", "", 
22, IsophaneInsulin_NPH, 686, 697, "NPH insulin", "", 
23, Metformin, 712, 721, "metformin", "", 
24, HbA1c, 757, 767, "HbA ( 1c )", "", 
274, Glucose, 790, 805, "diurnal glucose", "", 
117, SymptomaticHypoglycemia, 819, 844, "symptomatic hypoglycaemia", "", 
26, OpenLabel, 890, 894, "open", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
25, Parallel, 897, 913, "parallel - group", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
161, Multicenter, 939, 952, "seven centres", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
27, NumberPatientsCT, 955, 958, "110", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasNumberPatientsCT> \"110\"."
28, Precondition, 959, 1129, "insulin - naive type 2 diabetic patients with poor glycaemic control ( HbA ( 1c ) > or = 8 . 0 % ) on oral hypoglycaemic agents ( 90 % using sulfonylurea plus metformin )", "", "<http://ctro/data#Population_32828> <http://ctro/data#hasPrecondition> \"insulin - naive type 2 diabetic patients with poor glycaemic control ( HbA ( 1c ) > or = 8 . 0 % ) on oral hypoglycaemic agents ( 90 % using sulfonylurea plus metformin )\"."
29, Type2Diabetes, 975, 990, "type 2 diabetic", "", 
122, HbA1c, 1030, 1040, "HbA ( 1c )", "", 
121, Percentage, 1054, 1055, "%", "", 
123, OralAntidiabeticAgent, 1061, 1086, "oral hypoglycaemic agents", "", 
124, Sulfonylureas, 1100, 1112, "sulfonylurea", "", 
125, Metformin, 1118, 1127, "metformin", "", 
30, Randomized, 1135, 1145, "randomised", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
31, Bedtime, 1157, 1164, "bedtime", "", "<http://ctro/data#Intervention_32889> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Bedtime>."
32, InsulinGlargine, 1165, 1181, "insulin glargine", "", "<http://ctro/data#Medication_32901> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine>."
33, Metformin, 1187, 1196, "metformin", "", "<http://ctro/data#Medication_32915> <http://ctro/data#hasDrug> <http://ctro/data#Metformin>."
34, InsulinGlargine, 1199, 1200, "G", "", 
35, Metformin, 1203, 1206, "MET", "", 
38, Bedtime, 1212, 1219, "bedtime", "", "<http://ctro/data#Intervention_32895> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Bedtime>."
39, IsophaneInsulin_NPH, 1220, 1223, "NPH", "", "<http://ctro/data#Medication_32908> <http://ctro/data#hasDrug> <http://ctro/data#IsophaneInsulin_NPH>."
36, Metformin, 1229, 1238, "metformin", "", 
40, IsophaneInsulin_NPH, 1241, 1244, "NPH", "", 
37, Metformin, 1247, 1250, "MET", "", 
41, Duration, 1257, 1265, "36 weeks", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasCTduration> \"36 weeks\". <http://ctro/data#Intervention_32889> <http://ctro/data#hasDuration> \"36 weeks\". <http://ctro/data#Intervention_32895> <http://ctro/data#hasDuration> \"36 weeks\"."
51229, DoseDescription, 1272, 1332, "patients were taught how to self - adjust their insulin dose", "", "<http://ctro/data#Medication_32901> <http://ctro/data#hasDoseDescription> \"patients were taught how to self - adjust their insulin dose\". <http://ctro/data#Medication_32908> <http://ctro/data#hasDoseDescription> \"patients were taught how to self - adjust their insulin dose\". <http://ctro/data#Medication_32915> <http://ctro/data#hasDoseDescription> \"patients were taught how to self - adjust their insulin dose\"."
276, InsulinDose, 1320, 1332, "insulin dose", "", 
45514, FastingPlasmaGlucose, 1445, 1467, "fasting plasma glucose", "", 
42, FastingPlasmaGlucose_target, 1445, 1502, "fasting plasma glucose ( FPG ) of 4 . 0 to 5 . 5 mmol / l", "", 
45512, FastingPlasmaGlucose, 1470, 1473, "FPG", "", 
178, Millimoles_per_litre, 1494, 1502, "mmol / l", "", 
179, TimePoint, 1541, 1554, "last 12 weeks", "", 
44, FastingPlasmaGlucose, 1557, 1561, "FPGs", "", "<http://ctro/data#Endpoint_32836> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose>."
45, ResultMeasuredValue, 1571, 1577, "5 . 75", "", "<http://ctro/data#Outcome_36056> <http://ctro/data#hasResultMeasuredValue> \"5 . 75\"."
51, SdDevResValue, 1584, 1590, "0 . 02", "", "<http://ctro/data#Outcome_36056> <http://ctro/data#hasSdDevResValue> \"0 . 02\"."
46, ResultMeasuredValue, 1595, 1601, "5 . 96", "", "<http://ctro/data#Outcome_36083> <http://ctro/data#hasResultMeasuredValue> \"5 . 96\"."
52, SdDevResValue, 1608, 1614, "0 . 03", "", "<http://ctro/data#Outcome_36083> <http://ctro/data#hasSdDevResValue> \"0 . 03\"."
57, Millimoles_per_litre, 1615, 1623, "mmol / l", "", "<http://ctro/data#Endpoint_32836> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre>."
58, PvalueDiff, 1626, 1637, "p < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_36110> <http://ctro/data#hasPvalueDiff> \"p < 0 . 001\"."
60999, InsulinDose, 1644, 1657, "insulin doses", "", "<http://ctro/data#InsulinDose_32842> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#InsulinDose>. <http://ctro/data#Endpoint_32841> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#InsulinDose_32842>."
61000, ResultMeasuredValue, 1663, 1665, "68", "", "<http://ctro/data#Outcome_36119> <http://ctro/data#hasResultMeasuredValue> \"68\"."
61005, SdDevResValue, 1672, 1673, "5", "", "<http://ctro/data#Outcome_36119> <http://ctro/data#hasSdDevResValue> \"5\"."
61001, ResultMeasuredValue, 1678, 1680, "70", "", "<http://ctro/data#Outcome_36146> <http://ctro/data#hasResultMeasuredValue> \"70\"."
61004, SdDevResValue, 1687, 1688, "6", "", "<http://ctro/data#Outcome_36146> <http://ctro/data#hasSdDevResValue> \"6\"."
61008, BioAndMedicalUnit, 1689, 1697, "IU / day", "", "<http://ctro/data#BioAndMedicalUnit_32844> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_32841> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_32844>."
61002, ResultMeasuredValue, 1700, 1706, "0 . 69", "", 
61006, SdDevResValue, 1713, 1719, "0 . 05", "", 
61003, ResultMeasuredValue, 1724, 1730, "0 . 66", "", 
61007, SdDevResValue, 1737, 1743, "0 . 04", "", 
57595, IntUnit_per_Kg, 1744, 1749, "IU kg", "", 
57597, Interval, 1758, 1761, "day", "", 
62, InsulinGlargine, 1784, 1785, "G", "", 
61, Metformin, 1788, 1791, "MET", "", 
118, IsophaneInsulin_NPH, 1796, 1799, "NPH", "", 
60, Metformin, 1802, 1805, "MET", "", 
206, TimePoint, 1833, 1841, "36 weeks", "", 
266, Mean, 1844, 1848, "mean", "", "<http://ctro/data#Mean_32848> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_32846> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_32848>."
64, HbA1c, 1849, 1859, "HbA ( 1c )", "", "<http://ctro/data#Endpoint_32846> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
65, ResultMeasuredValue, 1864, 1870, "7 . 14", "", "<http://ctro/data#Outcome_36173> <http://ctro/data#hasResultMeasuredValue> \"7 . 14\"."
67, SdDevResValue, 1877, 1883, "0 . 12", "", "<http://ctro/data#Outcome_36173> <http://ctro/data#hasSdDevResValue> \"0 . 12\"."
66, ResultMeasuredValue, 1888, 1894, "7 . 16", "", "<http://ctro/data#Outcome_36200> <http://ctro/data#hasResultMeasuredValue> \"7 . 16\"."
68, SdDevResValue, 1901, 1907, "0 . 14", "", "<http://ctro/data#Outcome_36200> <http://ctro/data#hasSdDevResValue> \"0 . 14\"."
69, Percentage, 1908, 1909, "%", "", "<http://ctro/data#Endpoint_32846> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
70, SymptomaticHypoglycemia, 1934, 1993, "Symptomatic , but not confirmed symptomatic , hypoglycaemia", "", "<http://ctro/data#Endpoint_32851> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SymptomaticHypoglycemia>."
71, TimePoint, 2029, 2043, "first 12 weeks", "", "<http://ctro/data#Outcome_36227> <http://ctro/data#hasTimePoint> \"first 12 weeks\". <http://ctro/data#Outcome_36254> <http://ctro/data#hasTimePoint> \"first 12 weeks\"."
72, InsulinGlargine, 2051, 2052, "G", "", 
73, Metformin, 2055, 2058, "MET", "", 
217, ResultMeasuredValue, 2067, 2072, "4 . 1", "", "<http://ctro/data#Outcome_36227> <http://ctro/data#hasResultMeasuredValue> \"4 . 1\"."
45515, SdDevResValue, 2079, 2084, "0 . 8", "", "<http://ctro/data#Outcome_36227> <http://ctro/data#hasSdDevResValue> \"0 . 8\"."
219, BioAndMedicalUnit, 2085, 2110, "episodes / patient - year", "", "<http://ctro/data#BioAndMedicalUnit_32854> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_32851> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_32854>."
77, IsophaneInsulin_NPH, 2125, 2128, "NPH", "", 
74, Metformin, 2131, 2134, "MET", "", 
222, ResultMeasuredValue, 2143, 2148, "9 . 0", "", "<http://ctro/data#Outcome_36254> <http://ctro/data#hasResultMeasuredValue> \"9 . 0\"."
45517, SdDevResValue, 2155, 2160, "2 . 3", "", "<http://ctro/data#Outcome_36254> <http://ctro/data#hasSdDevResValue> \"2 . 3\"."
224, BioAndMedicalUnit, 2161, 2186, "episodes / patient - year", "", 
80, PvalueDiff, 2189, 2199, "p < 0 . 05", "", "<http://ctro/data#DiffBetweenGroups_36281> <http://ctro/data#hasPvalueDiff> \"p < 0 . 05\"."
45518, Glucose, 2249, 2277, "Glucose levels before dinner", "", "<http://ctro/data#Glucose_32857> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glucose>. <http://ctro/data#Endpoint_32856> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Glucose_32857>."
227, RelativeTime, 2264, 2277, "before dinner", "", 
82, IsophaneInsulin_NPH, 2297, 2300, "NPH", "", 
83, Metformin, 2303, 2306, "MET", "", 
85, ResultMeasuredValue, 2315, 2321, "10 . 1", "", 
87, SdDevResValue, 2328, 2333, "0 . 3", "", 
90, Millimoles_per_litre, 2334, 2342, "mmol / l", "", "<http://ctro/data#Endpoint_32856> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre>."
89, InsulinGlargine, 2357, 2358, "G", "", 
84, Metformin, 2361, 2364, "MET", "", 
86, ResultMeasuredValue, 2373, 2378, "8 . 6", "", 
88, SdDevResValue, 2385, 2390, "0 . 3", "", 
91, Millimoles_per_litre, 2391, 2399, "mmol / l", "", 
92, PvalueDiff, 2402, 2413, "p = 0 . 002", "", 
93, Duration, 2431, 2440, "36 - week", "", 
279, HbA1c_target, 2611, 2631, "HbA ( 1c ) < 7 . 0 %", "", "<http://ctro/data#Endpoint_32861> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target>."
96, BodyWeight, 2723, 2729, "weight", "", 
97, Insulin, 2766, 2773, "insulin", "", 
94, FastingPlasmaGlucose, 2788, 2791, "FPG", "", 
243, TimePoint, 2803, 2816, "last 12 weeks", "", 
100, ResultMeasuredValue, 2819, 2824, "5 . 7", "", 
102, SdDevResValue, 2831, 2836, "0 . 2", "", 
101, ResultMeasuredValue, 2840, 2845, "6 . 7", "", 
103, SdDevResValue, 2852, 2857, "0 . 3", "", 
98, Millimoles_per_litre, 2858, 2866, "mmol / l", "", 
244, SubGroupDescription, 2871, 2888, "patients reaching", "", 
245, SubGroupDescription, 2892, 2917, "those not reaching target", "", 
99, PvalueDiff, 2920, 2930, "p < 0 . 01", "", 
281, ConclusionComment, 2966, 3038, "Good glycaemic control can be achieved with both G + MET and NPH + MET .", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasConclusionComment> \"Good glycaemic control can be achieved with both G + MET and NPH + MET .\"."
104, InsulinGlargine, 3015, 3016, "G", "", 
105, Metformin, 3019, 3022, "MET", "", 
107, IsophaneInsulin_NPH, 3027, 3030, "NPH", "", 
106, Metformin, 3033, 3036, "MET", "", 
282, ConclusionComment, 3039, 3170, "Use of G + MET reduces symptomatic hypoglycaemia during the first 12 weeks and dinner time hyperglycaemia compared with NPH + MET .", "", "<http://ctro/data#ClinicalTrial_32808> <http://ctro/data#hasConclusionComment> \"Use of G + MET reduces symptomatic hypoglycaemia during the first 12 weeks and dinner time hyperglycaemia compared with NPH + MET .\"."
108, InsulinGlargine, 3046, 3047, "G", "", 
109, Metformin, 3050, 3053, "MET", "", 
112, SymptomaticHypoglycemia, 3062, 3087, "symptomatic hypoglycaemia", "", 
260, TimePoint, 3099, 3113, "first 12 weeks", "", 
261, Hypoglycemia, 3118, 3144, "dinner time hyperglycaemia", "", 
45511, RelativeTime, 3118, 3129, "dinner time", "", 
115, Hypoglycemia, 3130, 3144, "hyperglycaemia", "", 
111, IsophaneInsulin_NPH, 3159, 3162, "NPH", "", 
110, Metformin, 3165, 3168, "MET", "", 
116, PMID, 3220, 3228, "16456680", "", "<http://ctro/data#Publication_32787> <http://ctro/data#hasPMID> \"16456680\"."
